Abstract Implanted devices are mainly used to improve impaired function or to replace missing anatomic structures.
Introduction
Implants are increasingly used in many types of surgery, to improve impaired function, replace missing anatomic structure, or optimize appearance [1, 2] . Such devices are made out of different types of material, mainly metals and polymers, but also biological materials such as devitalized bone and blood vessels. Implant material is also called biomaterial [3] [4] [5] . Whereas vascularized tissues or foreign vital cells are not accepted by the host without immunosuppression, synthetic material and devitalized biological devices are rarely rejected. Nevertheless, the host reacts to such implants to different degrees which can be designated as biocompatibility [6, 7] .
A feared complication of implant surgery is bacterial or fungal infection. Staphylococci are the most common microorganisms causing implant-associated infections. In a large series on almost 600 prosthetic joint infections, 30% were caused by coagulase-negative staphylococci, 23% by Staphylococcus aureus, 9% by streptococci, and 6% by Gram-negative bacilli. However, virtually, all bacteria and fungi are able to cause implant-associated infection, including anaerobes and mycobacteria [8] . The increased risk for infection has been observed in orthopedic [9, 10] , cardiovascular [11, 12] , plastic reconstructive [13] , general surgery [14] , and neurosurgery [15, 16] . The first experimental proof for the increased susceptibility of foreign material to infection was provided by Elek and Conen [17] who showed that in the vicinity of suture material, the minimal abscess-producing dose was only 100 colony forming units (CFU) of S. aureus. This was >100,000-fold lower than in the absence of foreign material, an observation which was confirmed in an animal model of foreign body-associated infection [18, 19] . Whereas >10 7 CFU S. aureus did not produce any abscesses in the absence of foreign material, 100 CFU were sufficient to infect 95% of the subcutaneous implants (tissue cages) in guinea pigs ( Fig. 1) [18]. In the same animal model, extravascular devices could also be infected by the hematogenous route. With an experimental bacteremia of 10 3 CFU S. aureus per milliliter blood, seeding only to the device, and not to any additional site, was detected in 42% [20] . This experimental observation reflects the clinical data showing that S. aureus sepsis in patients with orthopedic implants results in prosthetic joint-associated infection in one third of the patients [21] [22] [23] .
During the last three decades, the pathogenic factors responsible for the enhanced risk for implant-associated infection have been elucidated by many different approaches [24] [25] [26] [27] [28] [29] . In brief, the increased susceptibility of implant material to pyogenic infections is due to impaired host defense at the implant site, and to the transformation of microorganisms in device-adhering biofilms. In this review, the main focus is on the threeway interaction between foreign material, host immune response, and the microorganisms adhering to implants.
Type of implants
The type of material is of minor clinical importance regarding the susceptibility of a device to infection. By testing bacterial adherence in vitro, it could be shown that biofilm-forming Staphylococcus epidermidis adhered to a higher degree on pure titanium than on stainless steel. However, this in vitro difference could not be observed in an in vivo model, where no differences in infection rates were observed when titanium and stainless steel implants were challenged with staphylococci [30] . Thus, the immediate protein coating of the implant by the host is more relevant for bacterial adherence than the type of material.
Medical devices can be used either transiently or permanently. Permanent devices, also called implants, can be classified according to their localization as intravascular or extravascular devices [31, 32] . This differentiation is useful since the interaction with the host is significantly different for the two types of devices. Whereas intravascular implants mainly interact with coagulation factors and circulating blood cells, extravascular implants interact with surrounding tissue, interstitial fluid, and attracted phagocytes [33, 34] .
Intravascular devices Vascular prostheses are used for revascularization in the case of arterial occlusive disease [12, 35] . In addition, patients with chronic renal failure undergoing hemodialysis need arteriovenous shunts which are typically made of synthetic material (Gore-tex® or Dacron®) [36] . Nowadays, the most common vascular implants are intravascular stents which are mainly used in interventional cardiology, but also to restore the blood flow in large vessels such as the aorta or the carotid artery [37, 38] .
Artificial heart valves are used for valvular stenosis or regurgitation [11, 39] . Interestingly, not only synthetic but also biological devices of devascularized tissue (e.g., porcine bioprosthesis) increase the susceptibility to infection. In a randomized prospective trial comparing mechanical heart valves with porcine bioprostheses, the risk for endocarditis was not statistically different, when measured at 10 and at 20 years [40, 41] . This indicates that a vascular biological material seems to behave like synthetic material in terms of susceptibility to infection.
Extravascular devices These implants are localized in different compartments of the host and have no direct interaction with the circulating blood. Orthopedic devices, such as prosthetic joints and internal fixation devices (nails, plates, and screws), are by far the most frequent implants in human medicine [9, 10, [42] [43] [44] . Despite the fact that joint replacement is a so-called clean procedure [45] , implant-associated infections are observed in 0.5% [18, 24, 55] (hip arthroplasty) to 7.5% (elbow or ankle arthroplasty) of the cases [9, 46] .
Host defense mechanisms
Innate or nonspecific host defense mechanisms are required for rapid and efficacious elimination of microorganisms causing implant-associated infection [18, 24, 25, 47]. As mentioned above, implanted devices are susceptible to virtually all types of bacteria and fungi [1, 48, 49] . Microorganisms are attacked by granulocytes or mononuclear phagocytes. Killing of bacteria by these cells depends on efficient phagocytosis and intracellular killing. For rapid ingestion of bacteria, opsonization of the microorganisms is essential. This involves nonspecific (complement, bacterial remnants) and in some microorganisms-specific soluble components (antibodies), as well as the corresponding receptors on the phagocytes. The process of phagocytosis involves chemotaxis, cell adherence to the microorganism, ingestion, killing, and digestion [50] . If this complex process is impaired at a given level, there is an enhanced risk of microbial persistence and therefore infection [51] .
In view of the susceptibility of implants to infection, various possible mechanisms for the impaired bacterial clearance have been hypothesized. In addition, the paradox of microbial persistence in the presence of abundant granulocytes around the implant has been studied.
Interaction of implanted device with host defense mechanisms
An implanted device interacts both with different host factors and with microorganisms. As soon as synthetic material is introduced in the body, it is covered by host proteins such as fibronectin, fibrinogen, and laminin. These proteins rather increase than decrease the risk for infection, because they act as mediators for bacterial adherence [52] [53] [54] . In addition, granulocytes and complement directly interact with the implant which may contribute to inflammation.
Frustrated phagocytosis Infections around implants occur after seeding of even very low numbers of bacteria to the device. Despite the presence of macrophages and granulocytes around the implant, these microorganisms cannot be cleared (Fig. 2) . Implant-associated infections never heal spontaneously, be it in humans or in experimental models using guinea pigs or mice with subcutaneous foreign bodies [18, [55] [56] [57] . Such infections are characterized by their protracted evolution. This is typically observed within the periprosthetic tissue. Moreover, bacteria persist at the implant site until spontaneous extrusion or surgical removal. In view of these clinical and experimental characteristics, it has been hypothesized that the interaction of granulocytes with a nonphagocytosable surface (i.e., implant), or alternatively with wear particles, may impair the function of granulocytes [18, 24, 58] . To test this hypothesis, a guinea pig model using subcutaneous tissue cages as foreign devices has been developed ( Fig. 1) [55]. Similar to the clinical observation, these implants (i.e., tissue cages) are highly susceptible to colonization by very low numbers of staphylococci. This is also true for socalled apathogenic bacteria such as S. epidermidis [19] or Propionibacterium acnes (unpublished data). In the inside of the tissue cages, interstitial fluid and phagocytes accumulate in close contact to the foreign surface. Fluid and phagocytes can be easily sampled by percutaneous puncture. Hence, with this model, local host defense mechanisms are accessible for ex vivo analysis (Fig. 1) . For example, it has been shown that granulocytes around the subcutaneous implant are unable to efficiently kill staphylococci, despite their adequate opsonization [18] . Also, opsonized particles are inefficiently ingested, and the granulocytes are partially degranulated and have a decreased production of oxygen radicals [24] . These observations could be further elucidated with in vitro experiments. When comparing the interaction of granulocytes with and without exposure to Teflon fibers, the respiratory burst and the extracellular release of specific granules are increased in granulocytes exposed to fibers. These granulocytes show a similar defect as tissue cage granulocytes, notably, as cells which interact with a Biomaterial surface activates neutrophils, but also induces a defect in subsequently added neutrophils [61] . These defects are likely due to the observed induction of degranulation of antimicrobial peptides (defensins) by the biomaterial, and hence impaired bactericidal activity [61] . This deactivation can be abrogated by specific antibodies to defensins. Another mechanism also resulting in impaired phagocytosis around implanted biomaterials has been proposed by Chang et al. [62] . They exposed neutrophils to different biomaterials used in vascular surgery. Their main finding was an enhanced production of oxygen radicals during neutrophil adherence to roughened but not smooth polystyrene surfaces. The reactive oxygenintermediates induce a nonapoptotic cell death [62] . Taken together, these interactions lead to neutrophil deactivation and premature cell death resulting in impaired microbial clearance around implants.
Since granulocytes around an implant are functionally impaired, the risk of bacterial adherence to the device is high. After adherence, many species of bacteria rapidly form a biofilm on the surface. Therefore, in implantassociated infection, granulocytes are mainly confronted with biofilm but not with planktonic bacteria. For efficacious clearance of adherent bacteria, leukocytes must penetrate the biofilm. Leid et al. [63] observed that leukocytes are able to penetrate S. aureus biofilms only under laminar-shear, but not static conditions. This finding may explain another observation. In infected vascular grafts, bacteria are almost always found on the outside and not on the luminal surface [64] . The luminal surface of vascular grafts is commonly smooth and eventually covered by endothelial cells. Hence, the bacteria mainly persist on the outer part of a vascular prosthesis, where laminar-shear forces are lacking [64] .
Interaction of implant with complement During contact of blood with the surface of an implant, complement is activated. This phenomenon has been observed in patients undergoing hemofiltration [65] , hemodialysis [66] , nylon fiber filtration leukapheresis [67] , heart valve exchange [68] , and vascular graft implantation [69] . In addition, complement activation also occurs on the surface of extravascular devices. This can result in local inflammation [70] . Polymer surfaces from subcutaneously implanted tissue cages ( Fig. 1 ) interact with interstitial fluid, but do not activate complement excessively [18] . However, even limited complement activation may have an impact on local inflammation by attracting phagocytes. Tang et al. [71] tested the importance of biomaterial surface properties in mediating in vivo complement activation. They evaluated different materials for their potency to activate complement in vitro and thereby to attract inflammatory cells on foreign material in a mouse model. For this purpose, they implanted devices of various materials intraperitoneally. They found a close relationship between surface-mediated complement activation in vitro and accumulation of phagocytes on polymer surfaces in vivo. These results show that complement activation is relevant not only upon blood-biomaterial interaction but also in extravascular devices interacting with interstitial fluid. Complement activation around implants or wear debris may therefore be the trigger of so-called aseptic loosening of joint prostheses [72] . DeHeer et al. [73] tested the ability of polyethylene to activate the complement cascade. Polyethylene is a component of artificial joints which is liberated as wear particles. It could be shown that polyethylene particles activate the alternative pathway of complement. In line with this in vitro observation, the authors could detect complement fragment Bb around polyethylene particles accumulating in synovial tissue of three patients. Since activated complement results in recruitment of inflammatory cells, these in vitro and in vivo observations support the hypothesis of implant loosening by wear particles.
In addition to the foreign body itself, the bacterial biofilm covering the implant activates complement also. S. epidermidis biofilms activate more complement than planktonically grown bacteria, as measured by C3a formation. Nevertheless, IgG and C3b deposition is diminished in biofilm-embedded bacteria, indicating their capability to evade phagocytosis [57] . Consequently, S. epidermidis persists within the biofilm on the implant, but does not cause massive inflammation, partially because 3b deposition is diminished. These experimental data parallel the clinical observation that bacteria embedded in a biofilm cause persistent low-grade infection. On the other hand, they explain loosening of the device because of local inflammation due to complement activation with C3a release, and hence, attraction of phagocytes around the implant [74] .
Degranulation-effect on the host Neutrophils interacting with foreign body material or with bacterial biofilm may harm the host. In orthopedic surgery, the most frequent cause for implant exchange is a noninfectious (i.e., aseptic) loosening of the device. There is an ongoing debate about the mechanism of implant loosening in patients without obvious signs of infection [75] . It has been hypothesized that at least some of these patients may have cryptic infection [76] . However, joint loosening can also occur without infection, by release of proteases into the interphase of implant and bone.
Incubation of host cells with Teflon fibers in a medium containing 50% plasma increases the oxidative metabolism of granulocytes but also releases specific granules. This in vitro stimulation and degranulation are relevant in vivo. Granulocytes purified from interstitial fluid surrounding subcutaneous tissue cages ( Fig. 1) are partially degranulated. Granulocytes, which interacted with an implant in vivo (i.e., tissue cage neutrophils), contain up to two thirds less myeloperoxidase, lysozyme, beta-glucuronidase, and B12-binding protein as compared to peritoneal exudate neutrophils [24] . Thus, azurophil (myeloperoxidase) as well as specific granules (B12-binding protein) are liberated upon interaction with the implanted polyfluoroethylene device. Since specific granules also contain proteases such as collagenase, one could speculate that the observed degranulation would result in loosening of bone-implanted devices. Indeed, in patients with peri-implantitis, matrix metalloproteinase 8 was detected in the peri-implant sulcular fluid [77] . This human neutrophil collagenase may lead to implant loosening. Along this line, it has been shown that hydroxyapatite particles (coating of artificial joints) activate granulocytes to release proinflammatory mediators, such as metalloproteinase [78] . Again, this local inflammation, induced by the interaction of granulocytes with biomaterial, may result in implant loosening due to the activity of collagenases.
Interaction of wear particles with phagocytes After arthroplasty, wear particles are produced in variable amounts depending on the biomechanical situation. In addition to the implant itself, these foreign particles also challenge the immune system. Bernard et al. [58, 79] described an impaired bactericidal activity of neutrophils after interaction with wear particles. They incubated host cells with ultrahigh molecular weight polyethylene particles which simulated in vivo wear debris. The bactericidal activity of neutrophils decreased in a time-and dose-dependent manner. Not only granulocytes but also macrophages are abundant in the peri-implant tissue where wear debris is present [80] . Macrophages try to eliminate wear particles and liberate cytokines upon phagocytosis. Cytokines, such as interleukin (IL)-1α, IL-1β, tumor necrosis factor (TNF)-α, macrophage colony-stimulating factor (M-CSF), transforming growth factor (TGF)-α, and many others have been detected in tissue surrounding orthopedic implants [81] . Some of these cytokines, such as M-CSF and TGF-α, directly stimulate osteoclastogenesis, which favors implant loosening by bone resorption.
Influence of neointimal healing
The crucial role of the neointimal healing on susceptibility to infection was described in a dog model, already 35 years ago [82] . In this study, the rate of prosthetic graft associated infection induced by intravenous bacteremic challenge with 10 7 CFU S. aureus dropped from 100% during the first 2 weeks after surgery to 30% 1 year after graft implantation. Interestingly, there was an excellent correlation between pseudointimal integrity and protection against hematogenous seeding. None out of 26 Dacron® grafts covered with an intima was infected during experimental bacteremia, whereas 95% (54/57) were infected in the case of incomplete or completely missing neointima [82] . This observation was later confirmed by testing different materials at different time intervals after surgery [83] . Dacron® grafts were superior to the polytetrafluoroethylene (PTFE) grafts with regard to susceptibility to bacteremic infection and to intimal lining. After 3 months, 70% (7/10) of the "Ultralight weight knitted Dacron®" grafts, but none out of 10 "PTFE-Gore-tex®" grafts, had complete neointimal lining on visual examination. Accordingly, only 10% of the Dacron®, but 70% of the Gore-tex® grafts, were infected after intravenous challenge with 10 8 CFU S. aureus. This underlines the crucial role of neoendothelization of the vascular devices against bacterial infection.
Not only vascular grafts but also septal defect-occlusion devices interact with blood components (complement, thrombocytes, granulocytes) and serve as an attractive site for bacterial adhesion. Therefore, rapid coverage by newly formed tissues is crucial. Foth et al. [84] analyzed 10 human septal defect-occlusion devices explanted from 5 days to 48 months after implantation due to mechanical reasons. With the exception of the implant with the shortest implantation time of 5 days, all specimens with an implantation time ≥10 weeks had a pseudointima with a structured arrangement of endothelial cells. In addition, within several months, neotissue was formed within the wire mesh of the implant. These experiments rationally support the clinical practice of anticoagulant or antiplatelet therapy for 6 months after implantation. Thus, it can be speculated that not only the risk for thromboembolic events but also the increased susceptibility to infection is markedly decreased after complete tissue coverage of the foreign device.
Phagocytosis of device-adherent bacteria
Microorganisms involved in device-associated infection attach to the foreign surface and grow as a so-called biofilm [85] [86] [87] [88] . Their phenotype is different from those in other types of infection where they exist in a planktonic stage. The process of biofilm formation has been extensively studies, especially with S. aureus and S. epidermidis. The first step of staphylococcal biofilm formation is adhesion to host proteins covering the artificial surface. [89] [90] [91] [92] . It is therefore conceivable that adherent bacteria are also more resistant than planktonic bacteria to phagocytosis and killing by host cells. Intact neutrophils show a significantly compromised elimination of biofilm bacteria. In a study by Vaudaux et al. [93] , >95% of the S. aureus adhering to polymethylmethacrylate survived exposure to purified neutrophils, as compared to <10% of planktonic staphylococci under otherwise identical conditions. More recently, Kristian et al.
[57] compared the survival of clonally identical biofilm and planktonic S. epidermidis. Biofilm staphylococci were significantly more resistant to neutrophils than planktonic staphylococci (67% survival vs 21% survival, p<0.03). This illustrates superbly that S. epidermidis belongs to the most important microorganisms in implant-associated infection, as observed in clinical practice. Despite its very low pathogenicity in the immunocompetent host, it has a high pathogenicity in the vicinity of an implanted device [94] .
Intracellular persistence of bacteria in implant-associated infections
Bacteria causing implant-associated infections may escape the first lines of immune defense by residing intracellularly. Host cells are either professional phagocytes (i.e., monocytes or macrophages), or nonprofessional phagocytes, such as endothelial or epithelial cells or fibroblasts. According to their association with host cells, bacteria can be classified into (1) obligate intracellular, (2) facultative intracellular bacteria, and (3) microorganisms that are traditionally considered extracellular pathogens but have the capacity to reside intracellularly. Obligate intracellular bacteria, such as Rickettsia spp., Chlamydia spp., or Coxiella burnetii, are unable to grow outside of host eukaryotic cells. Facultative intracellular bacteria, such as Mycobacteria spp., Listeria spp., Shigella spp., and Salmonella spp., are free-living organisms that naturally invade host cells. Finally, "small colony variants" of bacteria that are traditionally considered extracellular, such as Staphylococcus spp., Pseudomonas spp., or Escherichia coli, constitute a subpopulation of the identical microorganism but with distinctive phenotypic and pathogenic features allowing persistence within host cells [49, 95] .
Obligate intracellular bacteria Among the various bacterial genera belonging to this group, predominantly C. burnetii-the organism responsible for Q-fever-has been described in implant-associated infections, in particular in prosthetic heart valve [96] and vascular graft infections [97, 98] . The pathogenesis and clinical features of Q-fever have been described elsewhere [99] , and are beyond the scope of this review. However, after C. burnetii is phagocytosed by macrophages and monocytes, the DNA of Coxiella sp. can still be found in circulating monocytes and in the bone marrow, many years after primary infection [100] . Hence, the pathogen has specific strategies to survive in host cells, but escapes intracellular killing [100] [101] [102] . Because of this persistence, it is possible that host cells initiate the implantassociated infection. This hypothesis can be supported by two observations, illustrating an overlap between the host response to implant-associated infections and that to C. burnetii. Firstly, the pathogen causes a predominant lymphocyte infiltration at the site of infection. In 50% of vascular graft implants, irrespective whether or not an infection is present, a significant lymphocytic population is found [64] . Secondly, significant amounts of the cytokine IL-10 are observed in close proximity to implants [103] . On the other hand, high levels of IL-10 are associated with persistence of C. burnetii [104] . Therefore, circulating host cells containing C. burnetii may be involved at the implant site where they act as "Trojan horses."
Facultative intracellular bacteria Salmonella spp. and Listeria spp. as well as Mycobacterium tuberculosis and nontuberculosis Mycobacteria have been reported in association with both intravascular and extravascular foreign body infections [105] [106] [107] [108] [109] [110] [111] [112] . However, the host response to these bacteria is different. Salmonella spp. and Listeria spp. cause acute inflammation at the site of infection. In contrast, the immune response to Mycobacterium spp. is typically chronic.
Primary infection with M. tuberculosis occurs in the lung. This is followed by mycobacteremia in which small numbers of microorganisms disseminate to the implant by a mechanism that involves migration of mycobacteria within dendritic cells [111, 113] . Though, adherence and biofilm formation of M. tuberculosis on implant surface are not strong. Ha et al.
[30] compared these properties of S. epidermidis with those of M. tuberculosis on four different types of metal segments. M. tuberculosis rarely adhered to metal surfaces and showed very little biofilm formation. Similar results were reported by Chen et al. [114] who compared S. aureus and M. tuberculosis in vitro and in vivo. These data suggest that the immune response to mycobacterial implant-associated infection is not significantly different from that to other extrapulmonary infections.
Salmonella spp. and Listeria spp. invade nonprofessional phagocytes, but then escape from vacuoles into the cytosol [115] . Infected host cells express recognition patterns, which trigger a significant immune response. The specific interaction of host cells to implant-associated infections caused by Listeria spp. and Salmonella spp. is unknown. Listeria spp. can persist on stainless steel and produce biofilm in various amounts. On the other hand, strains with increased biofilm formation are phylogenically not associated with those causing invasive diseases [116] . Salmonella spp. can form biofilms on stainless steel, glass, and gallstones also [117] , but is rarely found in orthopedic implant-associated infections. Therefore, direct contact of facultative intracellular microorganisms with the foreign body seems not to be the major pathogenic factor. It can rather be hypothesized that these microorganisms invade and replicate within host cells in the periprosthetic tissue. As a consequence, the immune system deploys mechanisms to kill the bacteria, and hence, involves infected cells in an acute inflammation.
Small colony variants Small colony variants (SCVs) of bacteria are subpopulations with one tenth the size of normal colonies and therefore called SCVs. They can be internalized by and survive within a variety of nonprofessional phagocytic cells. SCVs have a decreased toxin production. Hence, they do not harm the host cell but persist intracellularly [118] . Various implant-related infections due to SCVs of S. aureus and E. coli have been described, including infections associated with pacemakers, ventriculoperitoneal shunts [119] , and prosthetic joints [49, 120] . Similar to other intracellular pathogens, the advantages for the bacteria include protection from antibodies, complement, and antibiotics that penetrate poorly into mammalian cells. However, in contrast to the obligate or facultative intracellular bacteria, intracellular SCVs replicate very slowly or not at all. The immunological host response to this type of infection is largely unknown. Neither antigen presentation with a serological response nor granuloma formation have been observed [118] . During phagocytosis of bacteria with normal phenotypes, a disruption of actin polymerization sets off the cytokine and chemokine alarm system. However, in SCVs, activation of the host immune system is only weak or absent. Certain bacterial genes involved in important virulence properties are inactivated or downregulated in SCVs. Thereby, infected epithelial cells remain viable without signs of disruption [121] . This poor stimulation of the immune system is supported by clinical findings in which SCV infections persist asymptomatically for many years [120, 122] . We investigated the pathogens and the periprosthetic tissue in a prosthetic hip-associated infection due to S. aureus that relapsed after a 23-month symptomfree interval [120] . Periprosthetic tissue culture also revealed SCVs. Examination of the tissue samples by electron microscopy demonstrated intracellular cocci within fibroblasts (Fig. 3) .
Biocompatibility: how to minimize noxious interactions
Biocompatibility refers to the ability of the biomaterial to perform its desired function in the body without eliciting adverse local or systemic effects in the recipient [123] . Biomaterial should generate the most appropriate beneficial cellular or tissue response in a given situation, and optimize the clinically relevant function of the treatment. The phenomenon of biocompatibility is reviewed in detail by Anderson et al. [6] . During the last decade, surfaces of prosthetic devices have been modified to improve biocompatibility [124] [125] [126] [127] . The ideal surface depends on the required function of the device. Artificial joints and internal fixation devices should be optimally integrated in bone, a process which is called osteointegration [128] . This can be achieved with nanostructured titanium. These nanophase materials enhance osteoblast cell proliferation and thereby favor osteointegration [124, 125, [129] [130] [131] . In addition, the incorporation of nanoparticles in bone cement has an antistaphylococcal effect [132] .
In intravascular devices, such as vascular grafts or stents, biocompatibility consists of minimal clotting activation and minimal bacterial adhesion to the foreign surface. As mentioned above, rapid neoendothelialization is crucial for the resistance of the vascular graft to bacterial seeding. This may be promoted by nanotechnology [133] . By using an appropriate nanotopography, it could be shown that endothelial cells cover polymers similar to natural vascular endothelium [133, 134] . This suggests that the nanotopography promotes a phenotypically correct morphology which potentially provokes minimal local thrombosis or bacterial adhesion.
On the other hand, hyperneoendothelialization decreases biocompatibility, also. Small stents used for coronary arteries are endangered by occlusion due to neointimal hyperplasia [135] . Therefore, drug-eluting stents releasing an antiproliferative drug (paclitaxel, sirolimus) have been developed [136, 137] . Drug-eluting stents have been shown to reduce neointimal hyperplasia, risk of restenosis, and need for repeated revascularization [138] [139] [140] [141] . Theoretically, drugeluting stents may have an increased risk for infection due to the delayed covering by endothelial cells, and thereby, favoring bacterial adherence. However, coronary stent infection is extremely rare, and drug-eluting stents have not been shown to be at increased risk for infection [142] [143] [144] .
Complement activation on device surfaces is a further important issue for biocompatibility because of its contribution to the coagulation pathway and local inflammation (see above "Interaction of implanted device with host defense mechanisms" section). Therefore, nanotechnology has also been tested for its influence on complement activation. It has been shown that complement activation is more pronounced when blood is in contact with a 200-nm than with a 20-nm-pore-size membrane [126] .
Recently, novel techniques of surface coating have been shown to prevent unspecific protein adsorption and optimize desired cell adhesion (e.g., fibroblasts) [145] ; thereby, bacterial adherence on the surface is inhibited [146, 147] . A further promising approach is the use of IL-12. This cytokine stimulates the Th1 response, and hence, activates macrophages, which may play a role at the interphase of the implant. The favorable effect of IL-12 nanoscale coating at the interface between implant and tissue could be demonstrated in a rat model. In open fractures treated with intramedullary bone fixation, the infection rate dropped from 90% to 20% when an appropriate IL-12 concentration was used for coating [147] .
Conclusions and outlook
Implants are not passive in the host. The foreign surface interacts with granulocytes, macrophages, and complement resulting in local inflammation. Due to the increased susceptibility to infection, even a minimal number of bacteria (e.g., 100 CFU S. aureus) can colonize the implant. Device-adhering bacteria transform into a biofilm which resists phagocytic killing as well as most antimicrobial agents. In view of these potential problems endangering the function of the device, strategies protecting implants from infection are needed.
There are some novel techniques that may minimize the susceptibility of implants to infection. Coating of the implant surface with antimicrobial substances such as antibiotics (minocyclin plus rifampin), antimicrobial peptides, or silver is an option. This strategy has been tested in vitro, in experimental models, and partially also in clinical medicine [148, 149] . An upcoming and promising technology is the use of "Microsystems Technology," also known as Micro-Electro-Mechanical Systems (MEMS). Ehrlich et al. [148] plan to develop a self-diagnosing, self-treating, and self-monitoring artificial joint that resists implant-associated biofilms. The concept is an implant with a MEMS-type biosensing device that perceives bacterial communication, also known as quorum sensing [149] . Quorum sensing is crucial for biofilm bacteria. It initiates after adherence of microorganisms on the surface of an implant. Interference with this quorum sensing and/or local release of antimicrobial agents upon sensing of an early biofilm may prevent clinical infection and loosening of the device. 
